True North Advisors LLC Acquires 512 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

True North Advisors LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 41.6% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,744 shares of the medical equipment provider’s stock after purchasing an additional 512 shares during the period. True North Advisors LLC’s holdings in Intuitive Surgical were worth $910,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Godsey & Gibb Inc. grew its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the third quarter worth approximately $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $36,000. Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical during the 3rd quarter valued at $38,000. Finally, DT Investment Partners LLC lifted its holdings in shares of Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 43,487 shares of company stock valued at $22,590,975. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $610.45 on Thursday. The stock has a market capitalization of $217.43 billion, a P/E ratio of 98.14, a PEG ratio of 5.13 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $362.14 and a 1-year high of $614.72. The business’s 50 day moving average is $543.14 and its two-hundred day moving average is $501.89.

Analysts Set New Price Targets

ISRG has been the subject of several research analyst reports. Raymond James lifted their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Robert W. Baird boosted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Royal Bank of Canada increased their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. Finally, Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.